NASDAQ:BMRN - Nasdaq - US09061G1013 - Common Stock - Currency: USD
Taking everything into account, BMRN scores 6 out of 10 in our fundamental rating. BMRN was compared to 568 industry peers in the Biotechnology industry. BMRN gets an excellent profitability rating and is at the same time showing great financial health properties. A decent growth rate in combination with a cheap valuation! Better keep an eye on BMRN. This makes BMRN very considerable for value and quality investing!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 6.11% | ||
ROE | 7.54% | ||
ROIC | 7.44% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 19.85% | ||
PM (TTM) | 14.96% | ||
GM | 79.67% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.11 | ||
Debt/FCF | 1.25 | ||
Altman-Z | 6.2 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 5.33 | ||
Quick Ratio | 3.29 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 26.68 | ||
Fwd PE | 18.07 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 23.78 | ||
EV/EBITDA | 16 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:BMRN (4/21/2025, 10:03:52 AM)
58.97
-0.2 (-0.34%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 26.68 | ||
Fwd PE | 18.07 | ||
P/S | 3.96 | ||
P/FCF | 23.78 | ||
P/OCF | 19.74 | ||
P/B | 2 | ||
P/tB | 2.17 | ||
EV/EBITDA | 16 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 6.11% | ||
ROE | 7.54% | ||
ROCE | 8.88% | ||
ROIC | 7.44% | ||
ROICexc | 9.06% | ||
ROICexgc | 9.91% | ||
OM | 19.85% | ||
PM (TTM) | 14.96% | ||
GM | 79.67% | ||
FCFM | 16.66% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.11 | ||
Debt/FCF | 1.25 | ||
Debt/EBITDA | 0.9 | ||
Cap/Depr | 101.03% | ||
Cap/Sales | 3.41% | ||
Interest Coverage | 54.69 | ||
Cash Conversion | 86.4% | ||
Profit Quality | 111.38% | ||
Current Ratio | 5.33 | ||
Quick Ratio | 3.29 | ||
Altman-Z | 6.2 |